December 9, 2025 · Form 4 insider transaction
RUBIN PAUL D bought 18,000 shares of BioAge Labs, Inc. at $6.57 per share, a transaction worth $118.3K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024.